Mirtle Medical
MiRTLE Medical: Innovating cardiac monitoring with diagnostic-grade devices and software for enhanced patient care.
Founded
2012MiRTLE Medical: Innovating cardiac monitoring with diagnostic-grade devices and software for enhanced patient care.
Founded with a mission to innovate cardiac monitoring, MiRTLE Medical provides advanced medical devices and software solutions designed for use inside MRI environments. Their core vision is to enhance patient care through precise positioning and real-time visualization during MRI procedures. MiRTLE Medical offers diagnostic-grade 12-lead ECG monitoring products, enabling new procedures such as ablation for arrhythmia, targeted chemotherapy, and tumor removal, while also making MRI accessible for trauma and high-risk patients.
MiRTLE Medical has attracted notable investors and industry experts dedicated to advancing medical technology. The company's key achievements include the successful integration of their cardiac monitoring devices in clinical settings, significantly improving patient outcomes. By expanding the capabilities of MRI procedures, MiRTLE Medical has made a substantial impact on the healthcare industry, providing safer and more effective diagnostic and treatment options for patients with complex medical conditions.
Companies similar to Mirtle Medical include Imricor Medical Systems, Atrility Medical, Monteris Medical and HeartVista.
Mirtle Medical was founded in 2012.
Mirtle Medical's headquarters is located in North Andover, MA, US.
Mirtle Medical's most recent funding round was for $525.4k (USD) in December 2021.
As of Dec 10, 2021, Mirtle Medical has disclosed funding of $1.5M (USD). Undisclosed round amounts are excluded.
Mirtle Medical has 4 employees as of Feb 5, 2024.
HeartVista
